BDBM102336 US10562854, No. C17::US8536181, C17::US9278930, C17

SMILES CC1CCC(CC1)NCc1ccn(Cc2ccccc2)c(=O)c1O

InChI Key InChIKey=VJHCNYYTYSQTGD-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 102336   

TargetEgl nine homolog 1(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102336(US10562854, No. C17 | US8536181, C17 | US9278930, ...)
Affinity DataIC50:  1.10E+4nMAssay Description:EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor A(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102336(US10562854, No. C17 | US8536181, C17 | US9278930, ...)
Affinity DataIC50:  2.74E+4nMAssay Description:ELISA assay using VEGF.More data for this Ligand-Target Pair
In DepthDetails US Patent